Intel senior fellow explains how AI and ML will personalise medicine, and what this means for business

Medicines tailored to the DNA of an individual, at scale, could soon be a reality. Intel Senior Fellow and Director of the Parallel Computing Lab, Pradeep Dubey, explains how high-performance compute, AI and machine learning are set to transform all aspects of healthcare, from diagnosis to drug discovery, and delivery. The rapidly increasing power of algorithms, Dubey adds, when deployed globally at scale, can cost effectively solve complex problems at the local level in a host of other industries, and business scenarios, significantly cutting time to market.